№ lp_1_10249
File format: docx
Character count: 8373
File size: 38 KB
This document outlines the submission requirements and details for cancer care delivery research studies within the NCI Community Oncology Research Program (NCORP), including information on study protocols, funding sources, and demographic accrual estimates.
Year:
2023
Region / City:
United States
Subject:
Cancer Care Delivery, Oncology Research
Document Type:
Submission Worksheet
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI Protocol Information Office
Target Audience:
Researchers, Investigators, Study Coordinators
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2019
Region / City:
United States
Topic:
Clinical Trials, Institutional Review Boards
Document Type:
Policy
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI
Target Audience:
NCTN and NCORP Sites, Clinical Trial Sites
Effective Period:
From March 1, 2019
Approval Date:
March 1, 2019
Modification Date:
Not specified
Date:
October 12, 2021
Time:
12 pm - 2 pm CT
Event Type:
Virtual workshop
Organization:
SWOG NCORP Research Base
Affiliated Program:
NCI Community Oncology Research Program (NCORP)
Subject Areas:
Cancer clinical trials; cancer care delivery research; cancer disparities; patient reported outcomes; accrual and recruitment
Leadership Mentioned:
SWOG NCORP Research Base Leadership; SWOG Statistics and Data Management Center (SDMC); HOPE Foundation
Agenda Topics:
NCORP Research Base overview; impact of COVID-19 on cancer clinical trial participation; patient reported outcomes; Accrual Quality Improvement Program (AQuIP); cancer care delivery portfolio updates; recruitment and retention; panel session
Geographic References:
San Antonio; Seattle
Participants:
SWOG NCORP members, committee representatives, statisticians, data coordinators, patient advocates, oncology research professionals
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified
Year:
2022
Region / City:
N/A
Topic:
VA Informed Consent Addendum, NCI CIRB, Boilerplate Language Revision
Document Type:
Guidance
Organization / Institution:
Department of Veterans Affairs (VA)
Author:
ORD, Office of Research Oversight (ORO), NCI CIRB
Target Audience:
VA Facilities, Research Community
Effective Period:
N/A
Approval Date:
April 6, 2022
Date of Updates:
May 12, 2022
Contextual description:
Guidance document on revisions to VA boilerplate language for NCI studies overseen by the NCI CIRB, detailing required actions for VA Facilities.
Year:
2010
Region / City:
United States
Subject:
Clinical Research Agreement
Document Type:
Cooperative Research and Development Agreement (CRADA)
Agency / Institution:
U.S. Department of Health and Human Services (HHS)
Author:
National Cancer Institute (NCI)
Target Audience:
Researchers, Medical Institutions
Effective Date:
Upon signing by the parties
Date of Approval:
December 8, 2010
Amendment Date:
N/A
Description:
A formal agreement between the U.S. Department of Health and Human Services and external collaborators for conducting clinical research.
Year:
2018
Region / City:
Dana-Farber/Harvard Cancer Center
Topic:
Research Consent Forms
Document Type:
Institutional Consent Language
Organization / Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
N/A
Target Audience:
Research participants and their legal representatives
Effective Period:
N/A
Approval Date:
10.04.2018
Date of Changes:
N/A
Year:
2020
Region / City:
United States
Subject:
NCI CIRB process for research protocol approval
Document Type:
Instructional Guide
Author:
NCI CIRB
Target Audience:
Investigators, research staff, and affiliated personnel
Period of Validity:
N/A
Approval Date:
2020
Date of Last Revision:
2020
Year:
2021
Region / City:
Wisconsin
Topic:
Informed Consent Form Template
Document Type:
Template
Organization / Institution:
Medical College of Wisconsin
Author:
NCI CIRB
Target Audience:
Researchers, Institutional Review Boards
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Year:
2027
Region / City:
United States
Theme:
Clinical Research, Institutional Review Boards
Document Type:
Agreement
Organization / Institution:
National Cancer Institute (NCI)
Author:
National Cancer Institute (NCI)
Target Audience:
Institutions involved in clinical trials
Period of Action:
Ongoing until the expiration of agreement
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / City:
United States
Topic:
Genomics, Implementation Science
Document Type:
Request for Approval
Organization / Institution:
National Cancer Institute (NCI)
Author:
Gila Neta
Target Audience:
Genomics researchers, NIH-funded researchers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Privacy Act Systems of Records Title:
Not specified
System or Records Notice Published:
No
Year:
2023
Region / City:
United States
Subject:
Clinical Trial Studies, Institutional Review Board (IRB)
Document Type:
Authorization Agreement, Confidentiality Statement
Organization / Institution:
National Cancer Institute (NCI), CIRB
Author:
National Cancer Institute
Target Audience:
Institutions participating in clinical trials
Effective Period:
Until March 31, 2026
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
1999–2019
Region / City:
Reston, Virginia, USA
Subject:
Information Technology Professional Services and Equipment
Document Type:
Federal Supply Schedule Pricelist
Organization / Institution:
NCI Information Systems, Inc.
Contract Number:
GS-35-F-0108K
Period Covered:
11/23/1999 – 11/22/2019
Special Item Number:
132-51
FPDS Codes:
D302, D306, D307, D308, D311, D317, D399
Ordering Address:
11730 Plaza America Drive, Reston, VA 20190
Phone / Fax:
(703) 707-6900 / (703) 707-6901
Website:
http://www.nciinc.com
Target Audience:
U.S. federal agencies and ordering offices
Delivery Scope:
Domestic and overseas
Payment Methods:
Government purchase card (up to micro-purchase threshold), wire transfer
Liability:
Contractor not liable for government personnel injury or property damage unless due to contractor negligence
Year:
2020
Organization:
U.S. National Cancer Institute, Center for Global Health
Document type:
Fellowship Application Supporting Statement
Program:
Post-baccalaureate Fellowship
Location:
Rockville, Maryland, USA
Applicant:
Balkissa Abdoulaye
Eligibility:
U.S. citizens and permanent residents with Bachelor’s or Master’s degree
Duration:
One-year, full-time, paid fellowship
Attachments:
Application form, cover letter, CV, transcript, two recommendation letters
Stipend:
Adjusted annually
Submission method:
Email
Confidentiality:
Information stored securely on NCI/NIH server
Annual government cost:
$12,940.40
Respondent cost:
$257.20
Burden hours:
10 hours per respondent
Type of source:
Administrative record for fellowship application
Year:
2025
Region / City:
Global
Theme:
Climate Change, Mitigation, Adaptation
Document Type:
Template
Institution:
Green Climate Fund (GCF)
Author:
Green Climate Fund (GCF)
Target Audience:
Project developers, accredited entities, national and regional stakeholders
Effective Period:
2025-2027
Approval Date:
2025
Date of Changes:
2025
Year:
2023
Region / City:
Texas
Topic:
Healthcare, Medicaid, EVV
Document Type:
Business Rules
Agency / Institution:
Texas Health and Human Services Commission (HHSC)
Author:
Texas Health and Human Services Commission
Target Audience:
Proprietary System Operators (PSOs), Medicaid providers, service providers
Effective Date:
August 1, 2023
Date of Approval:
January 2, 2023
Period of Validity:
Ongoing
Document Revision History:
January 2023
Year:
2024
Region / City:
Massachusetts
Theme:
Healthcare, Quality Assurance, Hospital Management
Document Type:
Technical Manual
Organization / Institution:
EOHHS (Executive Office of Health and Human Services)
Author:
EOHHS
Target Audience:
Hospitals, Healthcare Providers, Data Vendors
Period of Validity:
2025
Approval Date:
November 6, 2024
Modification Date:
Not specified
Year:
2022
Region / City:
United States
Topic:
Venture Capital Financing
Document Type:
Term Sheet
Organization / Institution:
Aumni
Author:
Aumni
Target Audience:
Investors, Business People, Legal Professionals
Effective Period:
Series A Preferred Stock Financing
Approval Date:
2022
Date of Amendments:
N/A
Note:
Year
Contextual description:
Overview of the Cisco® Channel Program Gold Integrator Partner Capability Review process, which includes audit preparation, discussion topics, and requirements for the PCR.
Year:
Not specified
Region / City:
Not specified
Topic:
Genome assembly, bioinformatics
Document type:
Research data / Supplementary material
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, geneticists, bioinformaticians
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2018
Region / City:
Penang, Malaysia
Topic:
DC Geared Motor with Encoder
Document Type:
User Manual
Organization / Institution:
Cytron Technologies Sdn. Bhd.
Author:
Cytron Technologies
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Description